Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 39 for “"Secondary hyperparathyroidism"”.
-
Experimental secondary hyperparathyroidism and the therapeutic application of vitamin D analogs
… mechanisms responsible for the development of secondary hyperparathyroidism (SHPT) in advanced renal insufficiency are phosphorus retention and low levels of 1,25-dihydroxyvitamin D[subscript]3 (1,25-(OH)[subscript]2D[subscript]3].;The actions of the hormonal form of vitamin D extend beyond its …
-
Characterizing the Development of Secondary Hyperparathyroidism and Vitamin D Resistance in Experimental Chronic Kidney Disease
… is a mainstay therapy for the treatment of secondary hyperparathyroidism (SHPT) that develops in CKD. A major issue with therapy includes the development of calcitriol resistance and increased vascular calcification. Modifications to the PTG that hinder its sensitivity to calcium (Ca) and …
-
Characterizing the Impact of Dietary Mineral Intake on Secondary Hyperparathyroidism, Vascular Calcification, and Bone Disease Within Experimental Chronic Kidney Disease
… factors: mineral bone disorder pathology and secondary hyperparathyroidism. Male rats had CKD induced using dietary adenine, and then were either sacrificed after induction, or challenged with a 12-day dietary intervention. 4 diets were used, assessing a combination of high vs low dietary PO4, …
-
Prevalencia de hiperparatiroidismo en enfermedad renal crónica 5 en terapia dialítica en Colombia
… of the real problem of the prevalence of secondary hyperparathyroidism (HPT2) in patients on dialysis that is a growing population worldwide due to the increase in the life expectancy of patients with chronic diseases. . HPT2 has been indirectly associated with worse survival outcomes in …
-
Η μεταβολή της οστικής πυκνότητας μετά τη χειρουργική αντιμετώπιση ασθενή με πρωτοπαθή ή δευτεροπαθή υπερπαραθυρεοειδισμό: προοπτική κλινικο-εργαστηριακή μελέτη
Introduction: Primary hyperparathyroidism as well as secondary hyperparathyroidism are associated, to a different degree, with changes in bone density. It has not been investigated fully to what degree bone density in primary and secondary hyperparathyroidism, is improved after surgical treatment. …
-
Bone health and vitamin D status among perinatally HIV-infected Asian children and adolescents with virological suppression
… >65 pg/ml were defined as hypovitaminosis D and hyperparathyroidism, respectively. Results: Of 396 participants, 57% were female and median age (IQR) was 15.0 (13.3-16.9) years. The prevalence of lumbar spine BMD and BMAD Z-scores <=-2 were 16.4% and 8.3%, respectively. Z-scores were lower with …
-
Μελέτη των μεταβολικών επιδράσεων της χορήγησης θεραπευτικών δόσεων βιταμίνης D σε ασθενείς με νοσογόνο παχυσαρκία που υποβάλλονται σε χειρουργείο χολοπαγκρεατικής εκτροπής
… mineral, and vitamin D deficiencies resulting in secondary hyperparathyroidism. Two groups of 35 and 37 healthy, obese (BMI, 50.4± 6.6 and 46.5±4.8 g/cm2), premenopausal, normally menstruating women were recruited who underwent LL-BPD. Both groups received high-calcium diets, 600 IU of vitamin D, …
-
Die renale Osteodystrophie
… 1980s the high turnover bone disease caused by secondary hyperparathyroidism and lack of vitamin D were predominant. Due to intensified application of vitamin D-metabolites in order to treat high turnover bone disease, increasing occurrence of diabetes mellitus and the higher age of patients, a …
-
Ινσουλινοαντίσταση και δείκτες καρδιακής δυσλειτουργίας σε χρόνιους αιμοκαθαιρόμενους ασθενείς
… hypertension, anemia, insulin resistance and secondary hyperparathyroidism. In the last years, studies had shown that, vitamin D plays an emerging role in cardiovascular pathophysiology. Until yet, only few studies have investigated the effect of vitamin D and insulin resistance on left …
-
Alteraciones del metabolismo del fósforo, fracturas por fragilidad y mortalidad en pacientes en hemodiálisis: estudio COSMOS
… el estudio COSMOS (Curren! Management of Secondary Hyperparathyroidism: a Multicentre Observational Study) permite ampliar el conocimiento sobre la influencia de los captores de fósforo y de los niveles bioquímicos y hormonales sobre la mortalidad y las fracturas óseas en una amplia …
-
Ανοσοϊστοχημική μελέτη βιολογικών παραμέτρων σε αλλοιώσεις των παραθυρεοειδών αδένων
… of parathyroid cells in culture. Primary and secondary hyperparathyroidism have no clear differences with regard to the histopathological features of the diseased parathyroid glands. The PRAD1 oncogene, subsequently identified as the gene encoding cyclin D1 has been shown to be important to …
-
Untersuchungen zum therapeutischen Einsatz von Calcium und Vitamin D-Metaboliten bei herzinsuffizienten und herztransplantierten Patienten
… insufficiency, strictly speaking hypogonadism, secondary hyperparathyroidism and vitamin D deficiency play a major role in bone loss. In order to create better conditions for a cardiac transplantation these risk factors must be monitored and treated adequately. With calcium substitution no …
-
Η εφαρμογή της υποδόριας χορήγησης ερυθροποιητίνης σε ασθενείς που υποβάλλονται σε συνεχή φορητή περιτοναϊκή κάθαρση
… THE COURSE OF INFECTION AND IN THE PRESENCE OF SECONDARY HYPERPARATHYROIDISM. THESE OBSERVATIONS SUGGEST THAT THE TWICE A WEEK SUBCUTANEOUS ADMINISTRATION OF RHUEPO IN CAPD PATIENTS IS EFFECTIVE IN ANEMIA CORRECTION, WHILE THERE IS ABSTRACT TRUNCATED
-
Διαταραχές του οστικού μεταβολισμού σε παχύσαρκα άτομα τα οποία έχουν υποβληθεί σε επέμβαση βαριατρικής
… (SG), to investigate the prevalence of secondary hyperparathyroidism (SHPT) as well as possible risk factors and finally to investigate the association between BsmI vitamin D receptor polymorphism and the markers of bone turnover and the indices of weight loss. Methods: This study was a …
-
ΣΥΣΧΕΤΙΣΗ ΤΗΣ ΟΣΤΕΟΚΑΛΣΙΝΗΣ ΚΑΙ ΤΟΥ ΠΡΟΚΟΛΛΑΓΟΝΟΥ-Ι ΜΕ ΤΟΥΣ ΙΣΤΟΜΟΡΦΟΜΕΤΡΙΚΟΥΣ ΔΕΙΚΤΕΣ ΤΗΣ ΝΕΦΡΙΚΗΣ ΟΣΤΕΟΔΥΣΤΡΟΦΙΑΣ
… PATIENTS (58%) SHOWED HISTOLOGICAL FINDINGS OF SECONDARY HYPERPARATHYROIDISM, 16 (18%) MIXED BONE DISEASE, 7 (8%) PATIENTS OSTEOMALACIA AND 13 (16%) APLASTIC BONE DISEASE. (ABSTRACT TRUNCATED)
-
Ein neues Tiermodell zur Analyse von Angiogenese und endokriner Funktion bei Transplantation von humanem Nebenschilddrüsengewebe auf die athyme Nacktmaus in vivo
… human parathyroid tissue from patients with secondary hyperparathyroidism was grafted into dorsal skinfold chamber preparations of athymic nude mi(CD1-nu BR; n=8). Equivalent pieces of the same human donor specimens were heat-inactivated and served as control grafts (n=7).Results:In all …
-
Investigating Minimally Invasive Stressors for Functional MRI of the Kidneys
… an annual mortality rate of 22% and can cause secondary complications including hypertension, anemia, secondary hyperparathyroidism, and malnutrition. Currently, clinical diagnosis and evaluation of CKD involves blood and urine testing and biopsy. MRI is not currently used to image CKD, but …
-
The prevalence and natural history of normocalcaemic hyperparathyroidism and hypoparathyroidism
Normocalcaemic hyperparathyroidism (NPHPT) is characterised by persistently normal calcium levels, elevated PTH values on at least two consecutive measurements, after excluding other causes of secondary hyperparathyroidism. The prevalence of the disease in the literature varies significantly due to …
-
Οστικός μεταβολισμός σε ασθενείς με καρδιακή ανεπάρκεια στεφανιαίας και μη αιτιολογίας
… 5,86 ; 95% CI 2,15–16,01 ; p:0,001). Conclusions Secondary hyperparathyroidism and reduction in bone density occur in CHF patients and are associated with disease severity. Secondary hyperparathyroidism maybe the underlying pathophysiologic mechanism of reduced bone density in CHF, by accelerating …
-
Characterizing the Impact of Vitamin D and High Dietary Phosphate on Parathyroid Gland Structure and Function in Chronic Kidney Disease
… dysregulation of phosphate metabolism promotes secondary hyperparathyroidism (SHPT), in which pathological parathyroid gland (PTG) calcium-sensing receptor (CaSR)-based signalling plays a significant role. Clinical interventions such as vitamin D-based treatments aim to control hypersecreting …
Page 1 of 2